Selected article for: "high cost and new drug"

Author: He, Binsheng; Hou, Fangxing; Ren, Changjing; Bing, Pingping; Xiao, Xiangzuo
Title: A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
  • Cord-id: wsfymnwx
  • Document date: 2021_7_22
  • ID: wsfymnwx
    Snippet: Drug repositioning is a new way of applying the existing therapeutics to new disease indications. Due to the exorbitant cost and high failure rate in developing new drugs, the continued use of existing drugs for treatment, especially anti-tumor drugs, has become a widespread practice. With the assistance of high-throughput sequencing techniques, many efficient methods have been proposed and applied in drug repositioning and individualized tumor treatment. Current computational methods for reposi
    Document: Drug repositioning is a new way of applying the existing therapeutics to new disease indications. Due to the exorbitant cost and high failure rate in developing new drugs, the continued use of existing drugs for treatment, especially anti-tumor drugs, has become a widespread practice. With the assistance of high-throughput sequencing techniques, many efficient methods have been proposed and applied in drug repositioning and individualized tumor treatment. Current computational methods for repositioning drugs and chemical compounds can be divided into four categories: (i) feature-based methods, (ii) matrix decomposition-based methods, (iii) network-based methods, and (iv) reverse transcriptome-based methods. In this article, we comprehensively review the widely used methods in the above four categories. Finally, we summarize the advantages and disadvantages of these methods and indicate future directions for more sensitive computational drug repositioning methods and individualized tumor treatment, which are critical for further experimental validation.

    Search related documents:
    Co phrase search for related documents
    • activation state and lung cancer: 1
    • activity base and acute sars cov respiratory syndrome coronavirus: 1